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Abstract
Introduction: Developmental exposure to estrogens has been shown to affect the musculoskeletal system.
Furthermore, recent studies have shown that environmental exposure to estrogen-like compounds is much higher
than originally anticipated. The aim of this study was to determine the effects of diethylstilbestrol (DES), a well-
known estrogen agonist, on articular cartilage, intervertebral disc (IVD), and bone phenotype.
Methods: C57Bl/6 pregnant mice were dosed orally with vehicle (peanut oil) or 0.1, 1.0, and 10 μg/kg/day of DES
on gestational days 11 to 14. Male and female pups were allowed to mature without further treatment until 3
months of age, when swim and sedentary groups were formed. After euthanasia, bone mineral density (BMD),
bone mineral content (BMC), bone area (BA), and trabecular bone area (TBA) of the lumbar vertebrae and femur
were measured by using a PIXImus Bone Densitometer System. Intervertebral disc proteoglycan was measured
with the DMMB assay. Histologic analysis of proteoglycan for IVD and articular cartilage was performed with
safranin O staining, and degeneration parameters were scored.
Results: The lumbar BMC was significantly increased in female swimmers at both the highest and lowest dose of
DES, whereas the femoral BMC was increased only at the highest. The males, conversely, showed a decreased BMC
at the highest dose of DES for both lumbar and femoral bone. The female swim group had an increased BA at the
highest dose of DES, whereas the male counterpart showed a decreased BA for femoral bone. The TBA showed a
similar pattern. Proteoglycan analysis of lumbar IVDs showed a decrease at the lowest doses but a significant
increase at the highest doses for both males and females. Histologic examination showed morphologic changes of
the IVD and articular cartilage for all doses of DES.
Conclusions: DES significantly affected the musculoskeletal system of adult mice. Results suggest that
environmental estrogen contaminants can have a detrimental effect on the developmental lumbar bone growth
and mineralization in mice. Further studies measuring the impact of environmental estrogen mimics, such as
bisphenol A, are then warranted.
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Introduction
Diethylstilbestrol (DES) is an estrogen agonist that was
widely used between 1947 and 1975 to prevent miscar-
riages and to suppress postpartum lactation [1]. A large
number of pregnant women were exposed to DES in
North America, Europe, and Australia. The National
Institutes of Health estimated that 5-10 million women
were exposed during pregnancy [2]. Its use in agricul-
ture was finally discontinued in 1979 [3]. The use of
DES was discontinued because of major adverse effects
on children born to DES-exposed mothers whose side
effects included, but were not limited to, clear-cell vagi-
nal adenocarcinoma in DES daughters, reproductive
organ defects in both DES sons and daughters, and var-
ious cancers [4]..
Evidence suggests that in utero exposure to DES can
induce epigenetic changes that affect the third genera-
tion [5]. The phenotype associated with these epigenetic
changes is not yet characterized. The youngest sons and
daughters that were exposed to DES (discontinued in
1971 in the United States) still have 15 reproductive
years left [6]. Understanding the effects of DES on var-
ious estrogen-responsive tissues thus continues to be
important today [4].
Estrogen affects articular cartilage and intervertebral
disc (IVD) turnover [7-10]. Its treatment in postmeno-
pausal women led to an increase in IVD height when
compared with that of untreated postmenopausal
women [8]. It was found to increase the synthesis of
proteoglycans in articular chondrocytes from surgically
menopausal monkeys [9] and to suppress collagen
breakdown in ovariectomized rats [10]. These results
indicate that estrogen can have a direct effect on adult
IVD and articular cartilage. Because DES is a potent
estrogen agonist [7], it would be reasonable to assume
that it could have an effect on the IVD, as well as
articular cartilage. Exposure of newborn mice to DES
induces permanent changes in skeletal tissue in adult-
hood, such as shorter femurs and increase in the
amount of bone in the femurs and vertebrae [11,12],
suggesting that physiological exposure to estrogens in
childhood might be one of the key factors in determin-
ing the final peak bone density in adulthood. However,
little is known about fetal exposure to DES on articular
cartilage and the IVD in male and female adult progeny.
Pregnant women were typically started on a low-dose
regimen of DES, which was escalated every 2 weeks to a
maximum dose of 0.15 g/day until the end of the preg-
nancy [8]. However, animal studies have shown that
even a transient exposure to DES can affect bone, both
during gestation and postnatally. A dose as low as 2 μg/
pup/day was previously used between postnatal days 1
and 5 to affect femoral and vertebral bone in females
[9]. Another study used doses ranging from 0.1 μg/kg/
day to 100 μg/kg/day between days 9 and 16 of gesta-
tion to examine the effect of DES on female femoral
and vertebral bone [10].
Environmental exposure to estrogen agonists like
bisphenol A have recently been described to be more
prevalent in urban areas [13]. It has also been suggested
that findings from the study of one estrogen agonist can
be extrapolated onto another [6]. In an aging popula-
tion, musculoskeletal health becomes ever more impor-
tant, as identifying risk factors for early fractures and/or
degenerative processes can help prevent significant mor-
bidity in otherwise vital members of society. This study
aims to examine the effects of a brief in utero exposure
to three different doses of DES on the musculoskeletal
system of adult progeny, which would shed light on the
possible increased risk of fracture in the sons and
daughters of mothers exposed to DES during gestation,
as well as in their children. Furthermore, this new-found
environmental exposure to estrogen agonists makes it
important to understand the full effects of such estrogen
agonists.
Materials and methods
All experiments were performed according to the guide-
lines of the Canadian Council of Animal Care and Ani-
mal Care Committee of the Lady Davis Institute for
Medical Research, consistent with those of the National
Institutes of Health.
Animal manipulation
Pregnant C57/bl mice were injected with either vehicle
(peanut oil) or one of three doses of DES (Sigma
Aldrich, Oakville, Ontario) (0.1, 1.0, and 10.0 μg/kg/day)
at 11 to 14 days of gestation. As described earlier, these
doses were previously shown to affect bone mass and
mineralization when used during gestation. A minimum
of three dams was set for each group. Pups were then
allowed to grow to adulthood without further interven-
tion until 3 months of age. At this point, mice were ran-
domized into two groups; one with a once daily
swimming regimen, which started at 5 minutes and was
escalated to a maximum of 1 hour within a week. Ani-
mals had 4 weeks of total swim time before being eutha-
nized. Mice from the second group were left to their
normal activity level and considered sedentary (see
Table 1). All animals were euthanized at exactly 4
months of age, weighed, and frozen at -20°C.
Bone densitometry analysis
Lumbar and femoral bones were evaluated by using
bone densitometry to determine whether in utero DES
exposure caused structural changes and whether this
effect was gender specific. Swim and sedentary groups
were compared to determine whether exercise
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potentiates the effect of DES on the musculoskeletal sys-
tem. The bone mineral density (BMD), generally mea-
sured to determine fracture risk clinically, was evaluated
as a surrogate marker of altered morphology [11]. The
lumbar and femoral regions of each intact mouse were
scanned by using the Piximus Bone Densitometry sys-
tem, as previously described [11]. BMD, bone mineral
content (BMC), bone area (BA), and trabecular bone
area (TBA) were all measured for both lumbar and
femoral bones. This was performed for all mice before
dissection for other investigations. The BA was evalu-
ated to determine whether the increase in mineral
deposits affected bone growth, whereas the TBA was
examined to determine bone quality.
Micro-CT
Dissected and fixed samples of lumbar spine and femurs
were placed in an imaging chamber. Percentage bone
volume, trabecular thickness, trabecular number, trabe-
cular separation, and distance between lumbar vertebrae
were determined with a desktop Micro-CT scanner (Sky-
Scan-1072; Skyscan, Aartselaar, Belgium) fitted with a
sealed microfocus x-ray tube with a spot size less than 8
μm that operates at 20 to 100 kV/0 to 250 mA. The spe-
cial x-ray CCD camera is based on high resolution (1,024
× 1,024 pixels) cooled CCD-sensor. The following set-
tings were chosen: X-ray source, 45 kV, and at 222 μA
resolution: 9.38 μm, rotation step: 0.9 degrees, exposure
time: 7,500 milliseconds. The resolution was chosen
because it was found to be optimal for measurements.
Reconstruction was performed by using NRecon (Sky-
Scan). CT-Analyser and 3D Creator (SkyScan) were used
for quantitative analyses and 3D rendering, respectively.
Histologic examination
The lumbar region and knee joint (mid femur to mid
tibia) were dissected from two animals per group for
histologic evaluation, fixed in 10% formalin for 18
hours, decalcified in formic acid for a maximum of 48
hours, dehydrated in graded solutions of ethanol in
water, infiltrated with xylenes, and finally paraffin
embedded, as previously described [12,14,15]. Sections
of 4 μm were cut with a microtome and placed on glass
slides. After deparaffinization, they were stained with
0.1% safranin O and counter stained with 0.02% Fast
Green. All slides were scanned by using the NDP view
software (Hamamatsu Corp., Hamamatsu, Japan). Sev-
eral parameters previously identified as correlated with
articular cartilage degeneration were evaluated and are
described in Table 2[16-18]. Selected parameters were
chosen from the Boos grading scheme to score IVD
degeneration, shown in Table 3[19]. Quantitative histo-
logic evaluation was not performed because of the small
number of animals, but the available data are included
for completion.
Proteoglycan content
Cervical to lumbar IVDs from three mice were isolated
and digested overnight at 56°C with proteinase K (Sigma
Aldrich, St. Louis, MO, USA). They were then vortexed
and centrifuged for 30 minutes at 2,800 g. IVD proteo-
glycans in the supernatant were measured by using the
DMMB assay [20]. Shark chondroitinase (Sigma Aldrich,
Cambridge, MA, USA) was used for the standard curve.
Standard curve was generated with concentrations ran-
ging from 10 μg/ml to 50 μg/ml, and colorimetric reads
were taken with a DU 640 spectrophotometer (Beck-
man, Carlsbad, CA) at 595 nm.
Statistical analysis
All statistical analyses were done by using ANOVA and
Fisher Least Significant Difference Post Hoc test with
StatView Software version 4.0 (SAS Institute, Cary, NC).
Assuming a comparison of means over the four dosage
groups, a sample size of five animals per group would
provide at least 80% power to detect a large effect size (f
= 0.86) against a null value (this is, no difference in the
means) at a critical test level of 5%. The effect size of
0.86 indicates that the standard deviation of the means
is 86% as large as the standard deviation of the observa-
tions. No statistical analysis was performed for histology
data because of the small sample size. Those results are
included as a point of interest and to supplement the
data obtained from imaging and proteoglycan analysis.
Results
Table 1 shows the number of pups born to each group
of dams. No significant differences were noted in terms
Table 1 Number of pups in each group
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aFemale or male mice were put on a once-daily swimming regimen, which started as 5 minutes and was escalated to a maximum of 1 hour within 1 week.
bFemale or male mice were left to their normal activity level and considered sedentary. cPregnant C57/bl mice were injected with either vehicle (peanut oil) or
one of three doses of DES (0.1, 1.0, and 10.0 μg/kg/day) at 11 to 14 days of gestation.
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of number of live births for each dosage of DES. Pups
born to different mothers were treated equally, because
the mothers were identical genetically and had no envir-
onmental differences other than the dose of DES given
during gestation.
Radiographic assessment
Several doses of DES significantly affected lumbar BMC,
BA, and TBA (Figure 1). The lumbar BMD was not sig-
nificantly affected at any dose of DES. The BMC was
measured to determine whether the lack of effect on
BMD meant that no changes in the calcium deposits
had occurred. Surprisingly, the lumbar BMC was
significantly increased at 10.0 μg/kg/day (18%; P =
0.0176) for the female swim group. However, it was sig-
nificantly decreased (8%; P = 0.0498) at 10.0 μg/kg/day
of DES in the male swim group (Figure 1).
The lumbar BA showed a significant increase at 10.0
μg/kg/day (7%; P = 0.0341) in the female sedentary
group and at both 0.1 (12%; P = 0219) and 10.0 μg/kg/
day (16%; P = 0.0006) in the female swim group. Lum-
bar BA in the male sedentary group showed a significant
decrease at 0.1 (2%; P = 0.0045) and at 1.0 μg/kg/day
(2%; P = 0.0218). The male swim group showed no sig-
nificant differences in lumbar BA, although a trend of
decreased lumbar BA compared with control was seen;
this did not reach statistical significance.
The lumbar TBA was not significantly affected in the
female sedentary group. The lumbar TBA in the female
swim group significantly increased at 10.0 μg/kg/day
(14%; P = 0.0178). The male sedentary group showed a
markedly significant decrease in lumbar TBA at 0.1 and
1.0 μg/kg/day (14% and 15%; P < 0.0001 for both), but
no significant difference was seen at 10.0 μg/kg/day. No
significant effect was seen in the male swim group lum-
bar TBA (Figure 1).
Fetal exposure to several doses of DES significantly
affected femoral BMD, BMC, BA, and TBA (Figure 2).
Femoral BMD was calculated to see whether the effect
of in utero exposure to DES had regional specificity.
Femoral BMD was significantly decreased in the male
swim group at 10.0 μg/kg/day (15%; P = 0.0055).
Table 2 Articular cartilage histologic evaluation criteria
Criteria for histologic evaluation of articular cartilage






0 No decrease in cells
1 Minimal decrease in cells
2 Moderate decrease in cells
3 Marked decrease in cells




2 One to three superficial clefts
3 More than three superficial clefts
4 One to three clefts extending into the middle zone
5 More than three clefts extending into the middle zone
6 One to three clefts extending into the deep zone
7 More than three clefts extending into the deep zone




2 Moderate (> 4 but ≤8)
3 Marked (> 8)
Tidemark integrity
0 Intact
1 Crossed by blood vessels
Tidemark duplication
0 No change
1 Duplication of tidemark
2 No visible tidemark remaining
Subchondral bone thickness
0 Subchondral bone thickness less than thickness of cartilage
1 Subchondral bone thickness equal to thickness of cartilage
2 Subchondral bone thickness more than thickness of cartilage
Table 3 Histologic evaluation parameters for the
intervertebral disc
Parameters Grade Description
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Otherwise, no significant effect on femoral BMD was
seen in the other groups. The femoral BMC was mea-
sured to evaluate whether the effect on BMD was con-
sistent with decreased mineral deposits in femoral bone.
No effect on femoral BMC was seen in sedentary
females (Figure 2). The swim female femoral BMC
showed a significant increase at 10.0 μg/kg/day (20%; P
= 0.0369). No effect was seen on femoral BMC in
sedentary males. The swim male femoral BMC showed
a markedly significant decrease at the highest dose of
DES (31%; P < 0.0001).
The female swim femoral BA significantly increased at
10.0 μg/kg/day (22%; P = 0.0361). The female sedentary
group femoral BA was not significantly affected by DES.
Both male swim and sedentary groups were affected at
the highest dose of DES exposure and showed signifi-
cant decreases in femoral BA (swim, 9%; P < 0.0001;
sedentary, 21%; P < 0.0001). At 0.1 and 1.0 μg/kg/day of
DES, males showed a decrease in femoral BA that did
not reach statistical significance.
The femoral TBA was not significantly affected in the
female swim group. The female sedentary group showed
a significant increase at 10.0 μg/kg/day (14%; P =
0.0186). Otherwise, no significant differences were seen
in femoral TBA. The male sedentary group showed a
10% decrease in femoral TBA at all doses of DES,
although it was not statistically significant (Figure 2).
The goal of micro-CT was to assess further the results
obtained with bone densitometry; thus only the control
and the highest dose of DES were analyzed for sedentary
females. Fetal exposure to DES had significant effects on
lumbar bone in terms of the percentage of bone volume,
trabecular separation, trabecular number, and distance
between lumbars (Table 4). The percentage bone
volume (PBV) is a measure of the quantity of cortical
bone with respect to total bone volume [21]. PBV signif-
icantly decreased at 0.1 μg/kg/day (8%; P = 0.014429)
and increased at 10.0 μg/kg/day (27%; P = 0.002076).
The trabecular separation, thickness, and number are
measures of the quality of cancellous bone [22] and
were evaluated to correlate the trabecular bone-area
measures to densitometry. The trabecular separation of
lumbar bone only significantly decreased at 10.0 μg/kg/
day (24%; P = 0.00235), but a 15% increase was noted at
0.1 μg/kg/day, which was not statistically significant.
The trabecular number in lumbar bone was significantly
increased at both the lowest and highest dose (24%; P =
0.029284; and 28%; P = 0.001317). The distance between
lumbars is a surrogate measure for IVD height [23]. It
was significantly decreased at 1.0 μg/kg/day (30%; P =

Figure 1 Lumbar bone densitometry with DES treatment. Bone mineral density (BMD), bone mineral content (BMC), bone area (BA), and
trabecular bone area (TBA) were measured in animals at death with a PIXImus Bone Densitometer System and analyzed by using a Windows
98-based software. Ratio of mean to control is plotted for each parameter plus the standard deviation. Significance was calculated in comparison
to the vehicles by using ANOVA and is reported when P < 0.05 versus peanut oil controls.
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0.00513). The trabecular thickness of lumbar bone was
not significantly affected by DES at any dose. This
increased trabecular number, coupled with a decreased
trabecular separation, correlates with the noted increase
in TBA and BMC at these doses of DES. These charac-
teristics are consistent with more-fragile bone.
Female sedentary femoral bone was not significantly
affected by fetal exposure to DES, but some trends were
noted (Table 5). The percentage bone volume showed an
average increase of 45%, which was not statistically signif-
icant because of one outlier. If this is disregarded, then
the difference is significant, with P = 0.02. The trabecular
separation was decreased by 35% with a nonsignificant P
= 0.07009. The trabecular thickness and trabecular num-
ber showed no significant changes at any dose.
Histology
Staining with safranin O of the IVD and cartilage, which
detects the chondroitin sulfate chains of aggrecan to
evaluate parameters, is described in Tables 2 and 3. Red
safranin-O staining was present throughout the tissue
(Figure 3).
Loss of staining, chondrocytes clones, and some struc-
tural changes were most notable in articular cartilage
from DES-exposed mice (Figure 3). Grossly, degenera-
tive changes were noted in articular cartilage of DES-
exposed animals at a higher rate than those in controls.
Figure 4 shows articular cartilage scores for each para-
meter analyzed and demonstrates that scores were con-
sistently higher in DES-exposed animals than in
controls.
IVD showed increased granular changes, chondrocyte
proliferation, and increased clefts and tears in both the
AF and the NP in response to in utero DES exposure
(Figure 5). Parameters associated with IVD degeneration
were found to have higher scores in DES-exposed mice
versus controls (Figure 6). Females exposed to DES
seemed to display more difference from controls than
did males exposed to DES, but more animals must be
tested to verify this pattern.
Proteoglycan
Proteoglycan content, predominantly aggrecan, was
determined because it forms a major structural compo-
nent of cartilage [24]. A higher proteoglycan content is
a hallmark of healthy IVDs, as it signifies an improved
ability to imbibe water, thus countering loads on the
spine [25,26]. Lumbar IVDs showed significant changes

Figure 2 Femoral bone densitometry with DES treatment. Bone mineral density (BMD), bone mineral content (BMC), bone area (BA), and
trabecular bone area (TBA) were measured in animals at death with a PIXImus Bone Densitometer System and analyzed by using a Windows
98-based software. Ratio of mean to control is plotted for each parameter plus the standard deviation. Significance was calculated in comparison
to the vehicles by using ANOVA and is reported when P < 0.05 versus peanut oil controls.
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in proteoglycan content at all doses of DES in females
and at only certain doses in the male swim group (Fig-
ure 7). Proteoglycan content in the female swim group
was significantly decreased compared with control at 0.1
μg/kg/day (28%; P = 0.0013) and 1.0 μg/kg/day (18%; P
= 0.0072), whereas a significant increase was noted at
10.0 μg/kg/day (20%; P = 0.0024). The female sedentary
group showed a significant increase in proteoglycan
content only at the middle and highest doses (51%; P =
0.0005; and 20%; P = 0.0172). This group showed a
decrease in the proteoglycan content at the lowest dose,
which was not statistically significant. The male seden-
tary group showed no significant changes in proteogly-
can content at any dose of DES. The male swim group,
however, showed significant increases at 0.1 and 1.0 μg/
kg/day of DES (62%; P < 0.0001; and 25%; P = 0.0063).
Discussion
Estrogen-responsive organs are affected by estrogen
imprinting well into adulthood [27]. These effects can
depend on the duration of exposure during gestation as
well as on the levels of estrogen [28,29]. Bone and
Table 4 Sedentary female lumbar micro-CT
Sedentary female Percentage bone volume (%BV/TV) Standard deviation P value
Control 13.19317 1.42201
μg/kg/day DES 0.1 12.18233 0.881048 0.014429
1.0 13.29047 0.259911 0.92804
10.0 16.80974 1.612495 0.002076
Trabecular separation (mm)
μg/kg/day DES Control 0.34907 0.045484
0.1 0.404715 0.010953 0.457184
1.0 0.321765 0.016935 0.616302
10.0 0.266997 0.020094 0.00235
Trabecular thickness (mm)
μg/kg/day DES Control 0.075187 0.003084
0.1 0.077025 0.000601 0.455911
1.0 0.078255 0.001237 0.236835
10.0 0.074538 0.001627 0.658458
Trabecular number (1/mm)
μg/kg/day DES Control 1.757235 0.200325
0.1 2.18268 0.016843 0.02928
1.0 1.698535 0.03334 0.70857
10.0 2.25342 0.189375 0.001317
Distance between lumbars (μm)
μg/kg/day DES Control 314.5833 44.74319
0.1 262.5 33.78959 0.097763
1.0 218.75 10.82532 0.00513
10.0 297.875 69.96584 0.579692
Table 5 Sedentary female femoral micro-CT
Sedentary female Percentage bone volume (%BV/TV) Standard deviation P value
μg/kg/day DES Control 1.81240 2.285448
10.0 2.636213 0.612359 0.578992
Trabecular separation (mm)
μg/kg/day DES Control 0.543937 0.137587
10.0 0.34779 0.015002 0.07009
Trabecular thickness (mm)
μg/kg/day DES Control 0.05791 0.007864
10.0 0.054943 0.003897 0.589679
Trabecular number (1/mm)
μg/kg/day DES Control 0.290977 0.340796
10.0 0.481133 0.114544 0.411454
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articular cartilage have already been characterized as
estrogen-responsive tissues [30,31]. More recent evi-
dence suggests that the IVD contains estrogen receptors
as well [32].
Developmental exposure to DES between 9 and 16
days of gestation was shown to increase both trabecular
and cortical femoral bone mass in female offspring [10].
No similar studies evaluated the effect on either male
offspring or the lumbar vertebrae. Although sexual
dimorphism does exist, when it comes to the bone
response to estrogen, estrogen-deficient males still have
low bone mass [33]. Estrogen-receptor alpha (ERa) and
beta (ERb) are mainly responsible for the effects of
estrogen on bone in both genders [34]. The involvement
of estrogen receptor-related receptor (ERR) was also
recently identified in the effects of estrogen on bone
[35]. Diethylstilbestrol is known to have an agonistic
effect on both ERa and ERR [35,36]. In light of these
data, it would be expected that an increased BMD
would be noted in both males and females, which would
most likely be due to an increase in BMC.
The current study demonstrated that the BMC and
TBA increased in adult females but decreased the over-
all bone size in males. This corresponds to more-fragile
bone in females and a feminized phenotype in males
because of the decreased bone size. The epigenetic
changes induced by DES can thus be responsible for
altering how bone responds to estrogen exposure
[37,38]. Hypermethylation of histone 2 occurred in cell
cultures exposed to DES and may play a part in the
effect on bone [39]. The effects were similar in both
lumbar and femoral bone, although lumbar bone was
more sensitive to lower doses of DES. Clinically, this
might imply vertebral fractures earlier in life, which can
be associated with significant morbidity [40]. If other
exercises that involve impact or high rates of load, such
as running or jumping, as opposed to swimming, were
evaluated, it is possible that lumbar and vertebral bone
would have similar results. DES cohorts can thus poten-
tially benefit from earlier screening with bone scans to
detect those vulnerable to vertebral or hip fracture.
In this work, because the mothers were all epigenetic
siblings and were treated exactly the same way during
gestation (except for DES dose given), no reason exists
to believe that pups born to different mothers have any
reason to be different, except for the dose of DES to
which they were exposed. All pups that received the
same dose of DES during gestation were treated as
being part of the same pool and randomized to swim or
sedentary groups accordingly. The only difference
between the sedentary and exercise groups was the exer-
cise regimen. According to our results, it seems that
exercise does potentiate the effects of DES. It could also
be that DES affects how the musculoskeletal system
responds to swimming. The fact that these differences
were observed without weight-bearing exercise makes
the results more striking. One of the limitations of the
study was the small sample size. The sample size used
in this study was determined based on the expense of
data collection and expedience.
Humans were typically exposed to DES throughout
gestation until birth [8]. The brief exposure in this study

Figure 3 Representative safranin O-fast green-stained
histologic sections. (a) Normal articular cartilage from female swim
control. Single-headed arrow shows chondrocytes clones. Double-
headed arrow demonstrates subchondral bone thickness. (b) Male
swim 1.0 DES limb; note abundant chondrocyte clones (single-
headed arrow) and fibrillation (arrowhead). (c) Male swim, 1.0 DES.
Note paucity of staining, chondrocytes proliferation, and duplication
of tide mark (white arrowhead).
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was chosen at a time of organogenesis; however, the
overall dose of DES in this study is much less than the
comparable dose used on pregnant women. Therefore,
the present results are more likely to underestimate the
effects of DES because the exposure was brief and at a
lower cumulative dose. In this study, no dose-response
relation was found. At first glance, this is not what one
would expect. However, the lack of a dose response is
actually typical for steroid hormones [38]. This is
because estrogen receptors can have different
downstream actions, depending on whether they were
exposed to low or high doses of estrogen [41] This is
why it is quite common to observe an effect at low and
high doses of estrogen (or estrogen agonists) but not at
intermediate doses.
DES is traditionally thought of as a pure estrogen ago-
nist, but can actually have an antagonistic effect in some
circumstances. It has an agonistic effect on ERa but an
antagonistic effect on ERR-g [42]. DES was most studied
in terms of its effect on the reproductive system, and it
was found to have a net agonist effect on these tissues
(endometrium, breast, prostate) [33]. How a tissue
responds to DES would largely be determined by the
receptor distribution in that tissue. A prevalence of ERa
in articular cartilage, for example, would lead us to sus-
pect an agonistic effect. Furthermore, it should be noted
that the effects observed in this study are due to “prim-
ing” with DES at a critical stage, which differs from
exposing an adult animal to DES. This priming can
change the receptor distribution in a particular tissue or
in the downstream pathways that a particular receptor
stimulates. These exact effects are not known at present
and must be further elucidated.
Contradictory evidence exists about the effects of
estrogen on articular cartilage [43]. Most studies, how-
ever, have concentrated on the effects of adult estrogen
exposure on articular cartilage, which contains ERa
[44]. Little is known about how estrogen imprinting
with DES can affect articular cartilage. The present
study found that even a brief 4-day fetal exposure to
DES can increase markers of articular cartilage degen-
eration in adult mice. Safranin O staining demonstrated
consistent decrease in proteoglycans for both males and
females at all doses of DES. This suggests that in utero

Figure 4 Histologic scores for articular cartilage at 16 weeks. Histologic parameters are compared between groups. Histologic analysis
revealed that loss of proteoglycan, based on safranin O-fast green staining in all four groups at all doses of DES.

Figure 5 Representative safranin O-fast green histologic
sections. (a) IVD from control female swim. Bold arrows show
cellular proliferation. Inset 1: white arrowhead shows cellular clones.
Inset 2: Black arrow shows AF fissuring grade 1. (b) IVD from 10.0
DES female swim group. White block arrow shows nuclear clefting.
Inset 1: Granulation under the endplate.
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Figure 6 Histologic scores of IVD at 16 weeks. Various histologic parameters of degeneration showed higher scores in DES-exposed groups
as compared with controls.
Figure 7 Lumbar intervertebral disc proteoglycan analysis. Whole intervertebral discs were analyzed with the DMMB assay. Significant
differences in proteoglycan content were noted at all three doses of diethylstilbestrol (DES), as compared with control.
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DES exposure can impair the ability of adult articular
cartilage to maintain its proteoglycan content. Estrogen
was shown to help maintain the integrity of articular
cartilage in sheep and rats [45,46]. The detrimental
effects seen here could be due to DES inhibiting the
response of articular cartilage to estrogen in both adult
males and females.
The intervertebral disc [IVD) was shown to express
estrogen receptor b (ERb) in the annulus fibrosus [32].
Diethylstilbestrol has an agonistic effect on ERb,
although it has a higher affinity for ERa [47,48]. These
findings suggest that the IVD is an estrogen-responsive
tissue, but no work has been done to study the effect of
in utero exposure to DES on the IVD. The present
study suggests that IVD in both male and female mice
fetally exposed to DES are more susceptible to disc
degeneration. Swimming ameliorated some of these
effects but exaggerated others, suggesting different
mechanisms of response to in utero exposure to DES.
Swimming was studied as an alternative to weight-bear-
ing exercise because it can have beneficial effects on
bone turnover, strength, and structure [49,50]. More
animals must be tested to corroborate that these degen-
erative changes are consistent.
Other than ERb, no other estrogen receptors were
detected in the IVD [51]. The altered proteoglycan con-
tent in DES mice can thus be a secondary effect. Sexual
dimorphism was also noted in the IVD response to in
utero DES exposure, replicating the pattern noted in
bone and articular cartilage.
Conclusions
In utero exposure to DES thus affected lumbar and
femoral bone of both male and female adult progeny.
Specifically, a higher BMC was noted in females, and a
decreased overall bone size was noted in males. These
findings correspond to more-fragile bone in females and
a feminized phenotype in males. Degenerative changes
were noted in the articular cartilage and IVD of rela-
tively young adult mice. DES cohorts could thus benefit
from earlier screening for signs of osteopenia or degen-
erative changes of their bone. ERa knockouts would be
a good next step in elucidating the mechanisms of DES
action on bone, articular cartilage and the IVD, as well
as studies in older mice. Studies with large sample sizes
are also warranted to corroborate the findings noted in
articular cartilage and IVD.
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